Cyrus S. Poonawalla

JetSynthesys announces Jetapult, the world's first I&O gaming startup, coming out of stealth with its first acquisition

Retrieved on: 
Friday, June 10, 2022
Leadership, VC, Textile, ANZ, Cyrus S. Poonawalla, Mark (given name), COO, Electronics, Company, CEO, Google Play, COVID-19, Ecosystem, DSP Group, Mangesh, Growth, Review, Technology, Acceleration, Acquisition, Research, MD, Industry, Steam, Learning, Engineering, Bennett, IGA, Principal, Video game, Investment, Suman Ramesh Tulsiani Technical Campus - Faculty of Engineering, Zynga

There are several talented gaming studios with great ideas who can truly scale themselves with the right mentorship and funding.

Key Points: 
  • There are several talented gaming studios with great ideas who can truly scale themselves with the right mentorship and funding.
  • With the three-pronged approach of Acquire, Invest, Accelerate, Jetapult is all ready to come out of stealth now, having already made one crucial acquisition.
  • Sharan Tulsiani, CEO & Co-Founder, Jetapultsaid, "Building high grossing hits in the gaming industry are often misrepresented to be luck-based, coin-flip endeavours.
  • The Jetapult I&O model will democratise gaming expertise and open opportunities at scale by partnering with talented studios in emerging markets.

JetSynthesys announces Jetapult, the world's first I&O gaming startup, coming out of stealth with its first acquisition

Retrieved on: 
Friday, June 10, 2022
Leadership, VC, Textile, ANZ, Cyrus S. Poonawalla, Mark (given name), COO, Electronics, Company, CEO, Google Play, COVID-19, Ecosystem, DSP Group, Mangesh, Growth, Review, Technology, Acceleration, Acquisition, Research, MD, Industry, Steam, Learning, Engineering, Bennett, IGA, Principal, Video game, Investment, Suman Ramesh Tulsiani Technical Campus - Faculty of Engineering, Zynga

There are several talented gaming studios with great ideas who can truly scale themselves with the right mentorship and funding.

Key Points: 
  • There are several talented gaming studios with great ideas who can truly scale themselves with the right mentorship and funding.
  • With the three-pronged approach of Acquire, Invest, Accelerate, Jetapult is all ready to come out of stealth now, having already made one crucial acquisition.
  • Sharan Tulsiani, CEO & Co-Founder, Jetapultsaid, "Building high grossing hits in the gaming industry are often misrepresented to be luck-based, coin-flip endeavours.
  • The Jetapult I&O model will democratise gaming expertise and open opportunities at scale by partnering with talented studios in emerging markets.

Serum Institute of India Initiates Manufacturing of Codagenix's Intranasal Live-Attenuated COVID-19 Vaccine Candidate

Retrieved on: 
Tuesday, September 22, 2020
Medical specialties, Economy of India, Health care, Serum Institute of India, Vaccines, Vaccine, Cyrus S. Poonawalla, RTT, Adar Poonawalla, Medical research

FARMINGDALE, N.Y., Sept. 22, 2020 /PRNewswire/ -- Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced that the Serum Institute of India has begun manufacturing CDX-005, the company's intranasal, live-attenuated vaccine candidate for SARS-CoV-2, the virus that causes COVID-19.

Key Points: 
  • FARMINGDALE, N.Y., Sept. 22, 2020 /PRNewswire/ -- Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, today announced that the Serum Institute of India has begun manufacturing CDX-005, the company's intranasal, live-attenuated vaccine candidate for SARS-CoV-2, the virus that causes COVID-19.
  • Codagenix, backed by investors Adjuvant Capital and TopSpin Partners, is collaborating with the Serum Institute of India, the world's largest vaccine maker by number of doses produced, to develop CDX-005.
  • It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute.
  • Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.